NNM Securities

COMPANY
more from company profile
HomeMarket Info Company Profile Smart Quotes

Smart Quotes

IPCA LABORATORIES LTD.

NSE : IPCALABBSE : 524494ISIN CODE : INE571A01038Industry : Pharmaceuticals & DrugsHouse : Ipca Laboratories
BSE1323.60-5.35 (-0.4 %)
PREV CLOSE ( ) 1328.95
OPEN PRICE ( ) 1339.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 10560
TODAY'S LOW / HIGH ( )1310.45 1339.05
52 WK LOW / HIGH ( )670 1373.95
NSE1323.95-5 (-0.38 %)
PREV CLOSE( ) 1328.95
OPEN PRICE ( ) 1335.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 260533
TODAY'S LOW / HIGH( ) 1310.55 1335.90
52 WK LOW / HIGH ( )669.8 1374.6
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 19-10 1949
Management Info
Premchand Godha - Chairman Pranay Godha - Managing Director
Registered Office

Address 48 , Kandivli Industrial Estate,Kandivli (West), ,
Mumbai,
Maharashtra-400067

Phone 022- 66474444 / 62106050

Email investors@ipca.com

Website www.ipca.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS
22Apr Ipca Laboratories informs about compli
Pursuant to Securities and Exchange Board of India (Listing Obligations..
19Apr Allotment Of Equity Shares Of Lyka La
Allotment of equity shares of Lyka Labs Ltd. on conversion of warrants
19Apr Allotment Of Equity Shares Of Lyka La
Allotment of equity shares of Lyka Labs Ltd. on conversion of warrants
27Mar Ipca Laboratories enters into Technolo
Ipca Laboratories has entered into a Technology Transfer Agreement with..
27Mar Ipca Laboratories gains on entering in
Ipca Laboratories is currently trading at Rs. 1208.25, up by 7.15 points..
MORE
Financials
Rs. in Millions
QTR Dec 23 ANNUAL 23
Net Profit1369.45057
Gross Profit 2001.5 7504.9
Operating Profit 2903.810230.4
Net Sales 15068.358146.2
MORE
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Fredun Pharma (BSE)
 827.60 (8.15%)
M.Cap (Rs. in Cr)390.76
Mankind Pharma (BSE)
 2393.90 (2.40%)
M.Cap (Rs. in Cr)95896.87
Torrent Pharma (BSE)
 2636.30 (1.76%)
M.Cap (Rs. in Cr)89224.37
Ajanta Pharma (BSE)
 2135.80 (2.17%)
M.Cap (Rs. in Cr)26893.07
Strides Pharma Scien (BSE)
 890.20 (5.24%)
M.Cap (Rs. in Cr)8180.91
MORE
Shareholding Pattern
PROMOTERS 46.3%
MUTUAL FUNDS/UTI 28.83%
NON-INSTITUTION 8.82%
FI/BANKS/INSURANCE 4.68%
GOVERNMENT 0%
FII 0%
MORE
Mf Holdings
MORE
ATTENTION INVESTORSKYCIPO
TERMS & CONDITIONS| PRIVACY POLICY| REFUND & CANCELLATION POLICY| DISCLAIMER| DISCLOSURE| KMP DETAILS | CDSL e-Voting | SEBI| FMC| NSE| BSE| MCX | SCORES
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
Assamese Bengali Gujrati Hindi Kanada
Kashmiri Konkani Malyalam Marathi Oriya
Punjabi Sindhi Tamil Telegu Urdu
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016|SEBI-PMS: INP000007100|LEI- 3358007DLCFNHY8J2F96

Filing compliant on SCORES – Easy & quick

  • Register on SCORES portal
  • Mandatory details for filing complaints on SCORES:
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • Benefits:
    • i.) Effective communication
    • ii.) Speedy redressal of the grievances
SMART ODR Portal
INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Copyright © 2021 NNM Securities.com

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.